Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-16

Clinical Trial Update: Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria [NA]

View source ↗

Summary

A terminated clinical trial investigated the effect of isoniazid on protoporphyrin levels in erythropoietic protoporphyria, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

Sponsor: University of Utah | Conditions: Erythropoietic Protoporphyria (EPP), X Linked Erythropoietic Protoporphyria | NA | Status: TERMINATED | Results posted: 2017-01-16